we reduced this number to 21 single base and 1 small insertion/deletion variants. Variants found in unrelated control DNA samples were excluded, as were those failing to segregate with DCM in affected family members. Only one variant remained, p. R870Q in TNPO3, which segregated fully with DCM in the family and was absent in 2528 unrelated DNAs. TNPO3, known as transportin 3 (or transportin-SR), is a member of the karyopherins, which function as nuclear import receptors for serine/arginine-rich (SR) proteins, key for mRNA processing and splicing. TNPO3 is remarkably highly conserved across all species, even to flies and yeast, with 94% similarity between human and zebrafish. No disease-causing mutations in TNPO3 or other karyopherins have been reported. The R870Q TNPO3 variant alters a highly conserved residue near to the carboxy terminus, and its C-terminus has been shown to interact with ASF/SF2 and SC35, both implicated in DCM and heart failure in murine gene-targeting studies. We therefore evaluated TNPO3 morpholino knockdown in zebrafish embryos, which was either lethal or resulted in severe development defects. In S. pombe fission yeast, over expression of wildtype but not the mutant human TNPO3 caused drastically reduced growth. In an E1A minigene system, useful to assess gene splicing, the TNPO3 R870Q variant increased 13S and 11S splicing isoforms and decreased a 9S transcript (pϽ0.05). We conclude that TNPO3 is a novel gene implicated in DCM, and that the R870Q TNPO3 variant adversely affects pre-mRNA splicing. Collectively the pedigree, molecular genetic, mRNA splicing and yeast data suggest that normal TNPO3 function may be key for survival and growth. 
A Parkin-Mitofusin Interaction Directs Cardiac Mitochondrial Culling Independent of Mitochondrial Fusion
Yun Chen 1 , yan Zhang 1 , Yingqiu Liu 1 , Scot J Matkovich 1 , Elizabeth Murphy 2 , Gerald W Dorn, II 1 ; 1 Washington Univ in St. Louis, saint louis, MO, 2 Systems Biology Cntr, NHLBI, NIH, Bethesda, MD Mitochondria account for 30% of myocardial mass, generating ATP to drive excitationcontraction coupling. Mitochondrial health is maintained by: 1) Dilution of damaged proteins/ genomes exchanged through organelle fusion/fission; and 2) Biogenic replacement of damaged organelles. We postulated involvement of mitochondrial outer membrane fusion proteins, mitofusins (Mfn), in cardiomyocyte mitochondrial fusion and culling. To interrupt cardiomyocyte mitochondrial fusion we concomitantly ablated Mfn1 and Mfn2. Embryonic ablation (Nkx2.5-Cre) of Mfn1/Mfn2 was lethal at e9.5. Conditional Mfn1/Mfn2 ablation in adult hearts (Myh6-MER-Cre-MER) induced rapidly lethal dilated cardiomyopathy with mitochondrial proliferation, fragmentation, and cristal dysmorphogenesis. Thus, mitochondrial fusion is required for cardiac homeostasis. Individual cardiac ablation (KO; Myh6-"turbo" Cre) of Mfn1 had no effect on cardiac structure or function, up to age 44 weeks, whereas cardiac Mfn2 KO induced progressive cardiac dilation (16 and 44 wks) with cardiac and cardiomyocyte contractile dysfunction, but normal sarcoplasmic calcium cycling (16 wks). Mfn1 KO mitochondria were normal in size and respiratory function. Mfn2 KO mitochondria also exhibited normal respiration, despite progressive (from 6 to 16 wks) organelle enlargement and bizarre/irregular morphologies. Over time, Mfn2 KO mitochondrial mass diminished and induced cardiomyocyte respiratory compromise. Consequences and mechanisms of mitochondrial abnormalities in Ͼ16 wk Mfn2 KO were: Mfn2 mitochondrial ROS production increased; Mfn2 mtDNA content decreased; DNA breaks (focal copy number aberrations and linear genomes) developed. Thus, Mfn1 is fully dispensible when Mfn2 is present, but Mfn2 is essential to prevent accumulation of damaged mitochondria, despite ongoing fusion. The Parkin ubiquitinase labels ROS-producing mitochondria for selective mitophagic culling in neurons. In our normal cardiomyocytes Parkin is cytoplasmic, but translocates to mitochondria after addition of uncoupling agent FCCP. FCCP-stimulated Parkin translocation is absent in Mfn2 KO cardiomyotes, revealing a unique requirement for Mfn2 to direct Parkin localization to uncoupled mitochondria. The importance of cardiac sodium channel Na v 1.5 is underscored by its critical role in the initiation and propagation of cardiac action potential. Because of its pivotal roles in determining the cardiac excitability and conduction velocity of electrical signals, defects in Na v 1.5 cause a spectrum of life-threatening cardiac arrhythmic disorders including Long QT syndrome (LQTS), Brugada syndrome (BrS), idiopathic ventricular fibrillation, cardiac conduction disease, congenital sick sinus syndrome (SSS), dilated cardiomyopathy (DCM), sudden infant death syndrome, and atrial fibrillation. However, no genotype-specific treatment strategies for these disorders exist. Novel intervention strategies are urgently needed.We recently identified a 20 kDa protein, MOG1, that interacts with Na v 1.5 at the intracellular loop connecting domains II and III. We discovered that over-expressing MOG1 in HEK293 cells and mouse cardiomyocytes enhances sodium current (I Na ) density without affecting Na v 1.5 gating kinetics. To investigate the potential of MOG1 as a therapeutic target for reduced I Na in sodium channelopathies, we co-expressed MOG1 with Na v 1.5 trafficking defective mutation D1275N associated with SSS, DCM, and atrial arrhythmias. Increased expression of MOG1 fully rescued the reduced plasma membrane expression of Na v 1.5 and decreased I Na densities caused by mutation D1275N. Likewise, BrS mutations R282H and P336L impaired Na v 1.5 trafficking and reduced I Na by Ͼ85%. Over-expressing MOG1 could increase the I Na by 2-fold. Interestingly, for all BrS mutations, increased MOG1 expression restored I Na in a heterozygous state (mixture of wild-type and mutant) to 73% to full level of a homozygous wild-type state. These results demonstrate that use of MOG1 to enhance Na v 1.5 trafficking to cell surface may be a potential personalized therapeutic approach in the future for some patients of BrS, DCM, and SSS with loss of function mutations in Na v 1.5. In stem cell-regulated organs, a subset of niches is characterized by low oxygen tension. This metabolic adaptation offers a selective advantage to stem cells favoring the preservation of their quiescent undifferentiated phenotype. The objective of this work was to determine whether in the mouse heart cardiac niches constitute a heterogeneous compartment composed of hypoxic and normoxic niches, and whether differences in O 2 concentration affect the function of c-kit-positive cardiac stem cells (CSCs). To test this possibility, we studied first the in vivo uptake of the hypoxic marker pimonidazole (PIMO), which identifies intracellular O 2 concentration Ͻ 10 mmHg. Mice were sacrificed 2 hours after intraperitoneal administration of PIMO, and PIMO-labeling was analyzed. By immunolabeling, 15% of cardiac niches were characterized by a hypoxic microenvironment and more than 20% of isolated CSCs were PIMO-positive, as measured by flow-cytometry. The cell cycle protein Ki67 was restricted to the PIMO-negative CSC class, which contained early committed cells expressing c-kit together with the myocyte specific transcription factors GATA4 and Nkx2.5. Mice were then administered tirapazamine, a compound that kills selectively hypoxic cells. One day later, the fraction of PIMO-positive CSCs was markedly decreased but, at 5 days, this compartment was partly reconstituted. This compensatory response was coupled with increased proliferation of PIMO-negative CSCs, suggesting that normoxic CSCs have the ability to replenish hypoxic niches following injury. Subsequently, the effects of hypoxia were studied in human CSCs (hCSCs) exposed in vitro to 1% O 2 . With respect to cells cultured in normoxia, 1% O 2 led to upregulation of HIF1␣ in hCSCs which also showed lower levels of BrdU incorporation. These cellular responses were accompanied by an increase in transcripts for the stemness genes c-kit, Oct4, Nanog and Sox2, and a decrease in mRNA for myocyte and vascular genes. Apoptosis, measured by TdT labeling, did not differ in normoxic and hypoxic hCSCs. In conclusion, our data indicate that hypoxic and normoxic niches coexist in the myocardium, and that intracellular hypoxia regulates the quiescent primitive CSC phenotype. 
Enhanced Survival and Myocardin-A Induced Cardiomyogenesis in Aged Mesenchymal Stem Cells Rejuvenated by Human Telomerase Gene Transfer
Rosalinda Madonna 1 , Shanshan Gao 2 , Raffaele De Caterina 3 , Yong-Jian Geng 2 ; 1 Texas Heart Institute -Houston and "G. d'Annunzio" Univ of Chieti, Houston, TX, 2 Texas Heart Institute -Houston, Houston, TX, 3 G. d'Annunzio" Univ, Chieti, Italy Background and Objective: Adult mesenchymal stem cells (MSCs) residing in old humans may respond poorly to tissue attrition or injury. Myocardin-A (McA) acts as a transcription cofactor for cardiomyogenesis while telomerase prevents cellular senescence. This study assessed whether gene delivery to over-express the catalyitic subunit of telomerase TERT and McA impacts survival, growth and myogenic differentiation in aged MSCs.Methods and Results: MSCs from the bone marrow of 24 month old C57BL/6 male mice were efficiently transduced or co-transduced with 3 th generation lentiviral vectors (SFFV-LTR-WPRE) carrying the cDNAs coding for TERT-YFP (yellow fluorescence protein) or McA-V5 epitope fusion proteins driven by a CMV promoter, at MOI 10 -40. Evidence for interaction between TERT and McA was obtained by co-immunoprecipitation and by bioluminescence resonance energy transfer assay. Transduction with TERT, and to a less extent, McA, but not empty vectors (mock) elevated cell viability (assessed by flow cytometry), proliferation (by BrdU uptake), and self-renewal (by colony formation). MSCs with TERT and McA transduction showed decreased apoptotic responses to Fas induction as they had lower levels of Annexin V and propidium iodide (PI) staining ( Fig. 1A and Table) . Increased expression of endogenous McA and smooth muscle ␣-actin occurred in MSCs with TERT overexpressed (nϭ3, pϽ0.05 by ANOVA vs mocktransduced) ( Fig. 1B) . MSCs with co-expression of both TERT and McA showed enhanced expression of cardiac and smooth muscle ␣-actin expression ( 
Hypoxic CD39 Knockout Mice Exhibit Severe Pulmonary Hypertension
Scott Visovatti, David Bushart, Anuli Anyanwu, David Pinsky; Univ Michigan, Ann Arbor, MI Background: The pathobiology of pulmonary arterial hypertension includes increased pulmonary vascular resistance, smooth muscle and endothelial cell proliferation, perivascular inflammatory infiltrates, and in situ thrombosis. These same processes are regulated by the purine nucleotides ATP, ADP, AMP via purinergic signaling pathways. Concentrations of these molecules within the extracellular, intravascular milieu are regulated in large part through the enzymatic activity of the ectonucleotidase CD39, which dephosphorylates ATP to ADP and AMP. We hypothesize that: 1) mice deficient of CD39 will have increased intravascular ATP; and 2) this increased ATP will be associated with a pulmonary hypertension phenotype including increased right heart pressures. Methods: Separate groups of C57/B6 wild type and CD39 knockout mice were exposed to normoxic and hypoxic (10% O2) environments for three weeks, resulting in four experimental groups. Right ventricular systolic pressures (RVSP) were measured by manometry using an open chest model. Circulating concentrations of ATP were measured using a luciferase assay. Statistical analysis was performed using Student t-tests. Results: CD39 knockout mice exposed to hypoxia exhibited a statistically significant increased RVSP (25.35ϩ/-1.35 mmHg) compared to both wild type (13.9ϩ/-1.1 mmHg) and CD39 knockout (16.35ϩ/-1.35 mmHg) normoxic mice. Circulating ATP levels in normoxic and hypoxic knockout CD39 mice were significantly increased compared to both wild type groups. Conclusion: CD39 knockout mice exposed to hypoxia exhibited 100-fold increases in circulating ATP levels, and were associated with increased RVSP. These data support the role of nucleotide levels in the pathogenesis of hypoxic pulmonary hypertension. Hypoxic CD39 knockout mice may be an advantageous rodent model for the study of other forms of pulmonary hypertension.
Late-Breaking Basic Science Poster Sessions 26382 Allogeneic Human Cardiosphere-Derived Cells Made From Unused Transplant Hearts
Agnieszka Blusztajn, Ileana Valle, Michelle Kreke, Linda Marban, Rachel R Smith; CAPRICOR INC, West Hollywood, CA, Allogeneic cardiosphere-derived cells (CDCs) are immunologically safe and functionally effective in animal models of myocardial infarction (MI). Therefore, the opportunity for an off-the-shelf CDC therapy now exists. Hearts obtained from organ donors but not used for transplant were collected from the National Disease Research Interchange and used to generate CDCs. Two hearts were obtained, both from male donors similar in age, one as a donation after cardiac death (DCD). When tissue was stored cold for 6 days prior to processing, 17% (4/24) of samples failed to yield CDCs; however, 3 days of cold storage had a negligible effect on growth rate (12Ϯ8 vs 12Ϯ10 M CDCs/g/d), and all frozen samples yielded CDCs even though cryopreservation did impact growth (2Ϯ1 M CDCs/g/d; pϽ0.05 vs fresh). CDCs were generated reliably using tissue from both the DCD and the non-DCD heart (nϭ15 samples from each); however, yields from the non-DCD heart were higher (20Ϯ15 vs 6Ϯ6 M CDCs/g/d; pϽ0.01). Tissue samples from the atria and right ventricle (nϭ6 from each region) yielded 3 to 7-fold more CDCs compared to other regions (atriaϭ26Ϯ6, RVϭ21Ϯ5, septumϭ6Ϯ2, apexϭ6Ϯ2, LVϭ4Ϯ2 M CDCs/g/d; ANOVAϭ0.003). The fraction of cardiac progenitors (c-Kit ϩ , MDR1 ϩ , or Sca-1 ϩ CDCs) or supporting cells (CD90 ϩ , DDR2 ϩ , or ␣SMA ϩ ) derived did not differ among regions and on average there were 1.6-fold more supporters than progenitors. Cardiac function was examined in a mouse model of MI at baseline and 3 weeks post-MI. Mice that received CDCs (nϭ23) showed an improvement in LV ejection fraction (40Ϯ7% to 47Ϯ8%; pϽ0.01) while control mice worsened (24Ϯ3% at 3 weeks; pϽ0.01 vs CDCs); however, CDCs derived from different regions led to similar improvements (ANOVAϭNS). CDCs subjected to an intermediate period of cryopreservation, or banking, could undergo an additional 15 population doublings before senescing, but were best utilized within 11 population doublings while still undergoing exponential growth. Post-thaw viability of CDCs averaged 80Ϯ8% and cryopreservation had a tolerable impact on subsequent growth (reduction in fold-increase of 12Ϯ2%). Due to the damage caused by warm ischemia, DCD hearts represent a group of organs largely unutilized for transplant. DCD hearts remain suitable for generation of CDCs and could yield a realistic estimate of 500 M CDCs per gram for allogeneic use. In conclusion, CDCs with similar functional potency can be derived from various regions of the heart and tissue as well as CDCs can be banked such that an entire adult heart could yield on the order of 125 B CDCs. 
Phosphoinositide 3-kinases p110␣ and p110␤ are Critical for Maintaining Cardiac Contractile Function and the Structural Integrity of T-Tubules in Myocytes
Chia-Yen C Wu 1 , Zhiheng Jia 1 , Wei Wang 2 , Lisa M Ballou 1 , Ya-Ping Jiang 1 , Biyi Chen 3 , Richard T Mathias 1 , Ira S Cohen 1 , Long-Sheng Song 3 , Emilia Entcheva 1 , Richard Lin 1 ; 1 Stony Brook Univ, Stony Brook, NY, 2 Baylor College of Medicine, Houston, TX, 3 Univ of Iowa Carver College of Medicine, Iowa City, IA, Phosphoinositide 3-kinase (PI3K) inhibitors are currently being used to treat cancer patients. However, PI3Ks regulate numerous physiological processes including some aspects of cardiac function. Although regulation of cardiac contraction by individual PI3K catalytic isoforms has been studied, little is known about the cardiac consequences of downregulating multiple PI3Ks concurrently. Here we report that genetic ablation of both the p110␣ and p110␤ PI3K isoforms in cardiac myocytes throughout development or in adult mice caused heart failure and death. Ventricular myocytes from double knockout animals showed transverse tubule (T-tubule) loss and disorganization. The structural alterations occurred prior to the development of heart failure in these animals. PI3K knockout myocytes also exhibited misalignment of L-type Ca 2ϩ channels in the T-tubules with ryanodine receptors in the sarcoplasmic reticulum. These changes resulted in reduced myocyte Ca 2ϩ transients and contractility. Junctophilin-2, which is thought to tether T-tubules to the sarcoplasmic reticulum, was mislocalized in the double PI3K-null myocytes without a change in expression level. Our results indicate that p110␣ and p110␤ are required to maintain the organized network of T-tubules that is vital for efficient Ca 2ϩ -induced Ca 2ϩ release and ventricular contraction, and suggest that PI3Ks maintain T-tubule organization by regulating junctophilin-2 localization. These results could have important medical implications because several PI3K inhibitors that target both p110␣ and p110␤ are in clinical trials. Our results indicate that patients treated with these drugs, especially patients with preexisting heart disease or those with diabetes who may already have reduced PI3K signaling in the heart, should be closely monitored for cardiac side effects. Partial inhibition of PI3K by these drugs could exacerbate the underlying cardiac dysfunction. 
Dose-dependent Regenerative Efficacy and Functional Improvement in Pigs with Ischemic Cardiomyopathy Injected Transendocardially With Allogeneic Cardiospheres
Kristine Yee, Konstantinos Malliaras, Hideaki Kanazawa, Eleni Tseliou, Linda Marban, Rajendra Makkar, Eduardo Marban; Cedars-Sinai Heart Institute, Los Angeles, CA Background: Open-chest injection of cardiospheres (CSps) and cardiosphere-derived cells (CDCs) is safe and effective in porcine ischemic cardiomyopathy (ICM). Using percutaneous methods, we first aimed to establish delivery and dosing protocols for optimal engraftment of CSps and CDCs using catheter-guided endomyocardial (EM) transplantation. Second, we performed a dose-ranging placebo-controlled study to test efficacy in porcine ICM.Methods: To quantify engraftment, 22 mini-pigs underwent balloon occlusion of theLAD for 2.5h. One month later, pigs received escalating doses (5-200x10 6 cells) of luciferaselabeled allogeneic CSps or CDCs by EM injection into the border zone (NOGA XP). Twenty four hours later, cardiac engraftment was quantified with the ex-vivo luciferase assay.The superior cell product was transplanted into 12 ICM mini-pigs by EM injections (nϭ15 each) consisting of: 1) vehicle; 2) low dose CSps (15x10 6 cells); 3) high dose CSps (45x10 6 cells); and 4) maximum feasible dose CSps (150x10 6 cells). Pigs underwent cardiac MRI before injection and 4 weeks later.Results: While percent engraftment remained constant with escalating doses of either cell product, overall engraftment of CSps was higher compared to CDCs (Fig 1A) . In the efficacy study, we used the product with superior engraftment (CSps); all doses preserved systolic function and attenuated remodeling compared to controls. The 150x10 6 CSp dose was superior in reducing scar size, increasing viable myocardium and improving ejection fraction (Fig 1B-D) .Conclusion: Catheter-guided EM delivery of heart-derived stem cells results in robust cardiac engraftment. Injection of CSps results in superior engraftment compared to CDCs. Dose-optimized injection of CSps preserves systolic function, attenuates remodeling, decreases scar size and increases viable myocardium in porcine ICM. The decreases in scar, mirrored by increases in viable myocardium, indicate genuine regeneration. 
Antisense Inhibition of ApoC-III in Rhesus Monkeys Reduces Plasma Triglycerides and Raises HDL-C Without Increasing Hepatic Fat
Mark J Graham, Tae-won Kim, Thomas A. A Bell, Adam E Mullick, Richard G Lee, Wuxia Fu, Rosanne M Crooke; Isis Pharmaceuticals, Carlsbad, CA, Genetic deficiency of human apoC-III results in lower serum triglyceride levels and is cardioprotective but as yet, no therapeutic agent has been developed to specifically target this apolipoprotein. Therefore, we developed species-specific antisense oligonucleotides (ASOs) to evaluate their potential beneficial effects in preclinical dyslipidemia models. In order to evaluate the pharmacology of a human/Rhesus-specific apoC-III ASO in a hypertriglyceridemic model, rhesus monkeys were maintained on a high fructose diet for 16 weeks prior to 12 week subcutaneous administration of the ASO (10mg/kg/wk). At study termination, a significant reduction in apoC-III hepatic mRNA and plasma protein was observed, (68% and 74%, respectively). Consistent with the loss of mRNA and plasma protein, a 27mg/dL reduction (from baseline) in total plasma triglycerides and 27mg/dL reduction in VLDL was observed in the apoC-III ASO treated cohort, while in the control animals, those parameters were increased by 27mg/dL and 28mg/dL, respectively. Interestingly, sustained apoC-III ASO treatment in these fructose fed monkeys also led to time-dependent increases in HDL-C levels of approximately 8 mg/dL. Importantly, 12 week apoC-III suppression did not increase in hepatic triglyceride accumulation. Finally, post-prandial plasma TG clearance was significantly increased by 38% in these monkeys after 10 week apoC-III ASO administration. Results in nonhuman primates demonstrate that antisense inhibition of apoC-III may represent an attractive therapeutic strategy for reducing plasma triglyceride and VLDL, while concurrently raising HDL-C levels in dyslipidemic individuals. Heart failure due to diastolic dysfunction exacts a major economic, morbidity and mortality burden in the United States. Therapeutic agents to improve diastolic dysfunction are limited. It was recently found that Dynamin related protein 1 (Drp1) mediates mitochondrial fission during ischemia/reperfusion (I/R) injury, and inhibition of Drp1 decreases myocardial infarct size. We hypothesized that Drp1 inhibition by Dynasore, a small noncompetitive dynamin GTPase inhibitor, could have beneficial effects on cardiac diastolic function during I/R injury. In Langendorff perfused mouse hearts subjected to I/R (30 minutes of global ischemia followed by 1 hour of reperfusion), pretreatment with 1 M Dynasore prevented I/R induced elevation of left ventricular end diastolic pressure, indicating a significant lusitropic effect. Dynasore also decreased cardiac troponin I efflux during reperfusion and reduced infarct size (Figure 1) . In cultured adult mouse cardiomyocytes subjected to serum depletion or oxidative stress, Dynasore increased cardiomyocyte viability identified by trypan blue exclusion assay ( Figure 2 ) and reduced cellular ATP depletion. Moreover, in cultured cells, Dynasore pretreatment protected mitochondrial fragmentation induced by oxidative stress. In conclusion, Dynasore protects cardiac lusitropy and limits cell death through a mechanism that maintains mitochondrial morphology and maintains intracellular ATP in stressed cells, which may have beneficial cardiac effects against clinical diastolic dysfunction. differed significantly from CTR in CGI at gene promoters ["promoter CGI", nϭ11, 967 ; Bayes factor (Bf): 533.0] and CGI within bodies of genes ("intra-genic CGI", nϭ8,092; Bf: 59.8), but not inter-genic CGI (nϭ7,068; Bf: Ϫ71.7) and CGI in 3'UTR of genes (nϭ512; Bf: Ϫ63.8). In EsCM, "promoter CGI" was more hypo-methylated whereas "intra-genic CGI" was more hyper-methylated and methylation in these subgroups differed more in the centre of CGI than in "CGI-shores". DNA methylation differences were present in promoters of upregulated genes (nϭ2,266; Bf: 12.6) but not down-regulated genes (nϭ1,919; Bf: Ϫ48.3). H3K36me3-enrichment itself was also significantly different in coding regions. Specifically, abundance of RNA transcripts encoded by the DUX4 locus correlated to differential DNA methylation and H3K36me3-enrichment. In vitro, Dux gene expression was responsive to a specific inhibitor of DNA methyltransferase and Dux siRNA knock-down led to reduced cell viability.Conclusions: Distinct epigenomic patterns exist in important DNA elements of the cardiac genome in human EsCM. The epigenome may control the expression of local or distal genes with critical functions in myocardial stress response. If epigenomic patterns track with disease progression, epigenome assays may be useful for assessing prognosis in heart failure. Further studies will be needed to determine whether and how the epigenome contributes to the development of cardiomyopathy. Angiopoietin-1 Reduces Myocardial Infarction via Upregulation of SDF-1/CXCR-4 and Recruiting Hematopoietic Progenitor Cells in the Diabetic db/db Mouse Model Heng Zeng, Jian-Xiong Chen; Univ of Mississippi Med Cntr, Jackson, MS, Objective: Bone marrow (BM) derived hematopoietic progenitor CD133 ϩ cells have been shown to be involved in the healing of ischemic injury following myocardial infarction (MI). Previously we demonstrate the angiopoietin-1(Ang-1) is beneficial in the repair of diabetic infarcted hearts and is a promising new candidate for therapy. The present study investigates whether Ang-1 affects CD133 ϩ cells recruitment to the infarcted myocardium and mediates cardiac repair in type II diabetic mice.Research Design and Methods: db/db mice were systemic administration of adenovirus Ang-1 (Ad-Ang-1) or Ad-␤-gal, and subjected to myocardial ischemia for 24 hours and 14 days. Myocardial Ang-1, CXCR-4, SDF-1␣, Jagged-1 and Notch3 expression was measured. The recruitment of cardiac CD133 ϩ , CD133 ϩ /CXCR-4 ϩ , CD133 ϩ /SDF-1␣ ϩ cells, cardiac apoptosis, and MI size were analyzed. The number of BM-derived CD31 ϩ (BM-CD31 ϩ ) and smooth muscle-like cells (BM-SMA ϩ ), BM-derived VEGF, capillary density and arteriole formation were also examined.Results: Systemic administration of Ad-Ang-1 led to overexpression of Ang-1in db/db mouse hearts and BM after MI.
Overexpression of Ang-1 resulted in significant increases in CXCR-4 and SDF-1␣ expression and promoted CD133 ϩ cells recruitment into ischemic hearts. The increased cardiac CD133 ϩ cells co-localized with CXCR-4 ϩ and SDF-1␣ ϩ cells in the Ad-Ang-1 treated db/db mice. Overexpression of Ang-1 significantly attenuated cardiac apoptosis and infarct size. Overexpression of Ang-1 led to a significant increase in number of BM-CD31 ϩ and BM-SMA ϩ cells and VEGF expression in BM. This was accompanied by a significant increase in myocardial capillary density. Ang-1 also upregulated Jagged-1 and Notch3 expression followed by increases in VSMC recruitment and newly formed arterioles in the border zone of infarcted myocardium. Conclusion: Our data strongly suggest that Ang-1 attenuates cardiac apoptosis and infarction by promoting recruitment of hematopoietic progenitor CD133 ϩ and BM-CD31 ϩ cells. Ang-1 gene therapy may represent a novel therapeutic strategy for the treatment of diabetes-associated heart failure after MI. 
A New Page in the Story of High-Fat Diet Induced Adipose Tissue Inflammation: A Novel Macrophage Activation Regulator, miR-223
Beiyan Zhou; Texas A&M Univ, College Station, TX, Atherosclerosis associated complications account for more than half of CVD related mortality annually. Growing evidences indicated the pivotal role of macrophage mediated inflammation is one of the crucial factors for the pathogenesis of both atherosclerosis and T2DM. Macrophage plays a central role in the innate immunity and facilitates the establishment of adaptive immunity. However, when infiltrated into the vessel wall and adipose tissue, pro-inflammatory macrophages interact with epithelial cells and adipocytes, resulting in altered cell behaviors, and eventfully leading to the onset of adipose tissue inflammation and obesity-associated insulin resistance. Here we show that miR223, a microRNA that has the most abundance in the bone marrow, critically regulates systemic insulin sensitivity and adipose tissue inflammatory response in mice. Upon feeding a high-fat diet (HFD), miR223-deficient mice exhibited a greater increase in the severity of systemic insulin resistance compared with wild-type littermates. Additionally, miR223-deficiency mice exhibited a marked increase in HFD-induced adipose tissue inflammatory response. In an in vitro system, miR223-deficient macrophages showed an increase in proinflammatory activation and a decrease in alternative activation. Consequently, co-culture of miR223-deficient macrophages with wild-type adipocytes led to increased adipocyte inflammatory response and decreased insulin signaling. Through computational survey and the report assays, several genes that are crucial for macrophage activation are identified as miR-223 targets. Together, these results suggest that miR223 acts through modulating macrophage polarization to protect against diet-induced insulin resistance and adipose tissue inflammatory response, thus provide a new layer of regulatory circuit in the network governing adipose tissue inflammation. A pool of primitive cells with stem cell properties has been identified in the fetal and adult mammalian heart. Resident cardiac stem cells (CSCs) express c-kit, the receptor for stem cell factor (SCF) which may activate signaling pathways leading to intracellular Ca 2ϩ mobilization. Thus, we tested whether SCF modulates Ca 2ϩ homeostasis in CSCs and whether changes in cytosolic Ca 2ϩ level promote proliferation and differentiation of this cell compartment. For this purpose, we utilized transgenic mice in which GFP expression was under the control of the c-kit promoter. Cytosolic Ca 2ϩ was measured by two-photon microscopy in CSCs loaded with Ca 2ϩ indicators. Approximately 10% of CSCs displayed Ca 2ϩ elevations lasting 60Ϯ1 sec. Exposure to SCF led to a 2-fold increase in the fraction of cells experiencing oscillatory events. A similar effect was obtained when PLC function and inositol triphosphate (IP3) production were stimulated with Gq-protein coupled receptor agonists. In contrast, IP3 receptor blockade or downregulation via small hairpin-RNA reduced the fraction of cells displaying Ca 2ϩ oscillations. The duration of the different phases of the cell cycle was determined in CSC by the labeled mitosis method and synchronized cell preparations indicated that oscillatory events were maximal (Ͼ30%) in G1 and G2. Importantly, stimulation of IP3 receptor-Ca 2ϩ mobilization promoted the progression of G1 synchronized CSCs into the S phase of the cell cycle, documented by a 1.9-fold increase in BrdU incorporation. IP3 receptor blockade or downregulation led to opposite results. In a similar manner, Ca 2ϩ oscillations were modulated in CSCs in G2 and the pattern of cell division and lineage specification were evaluated during the late mitotic phase. This was accomplished by the analysis of the distribution of the cell fate determinant alpha-adaptin and the expression of the myocyte transcription factor Nkx2.5 in the two daughter cells. While symmetric cell division predominated under baseline conditions, stimulation of Ca 2ϩ oscillations during the G2 phase significantly increased the fraction of CSCs undergoing asymmetric cell division and myocyte lineage specification. Thus, Ca 2ϩ mobilization via IP3 receptors regulates the growth and commitment of CSCs. 
